Multimodality Treatment with Radiotherapy for Huge Hepatocellular Carcinoma
暂无分享,去创建一个
[1] J. Seong,et al. Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy , 2014, Annals of Surgical Oncology.
[2] Y. Sugawara,et al. Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma , 2014, Liver Cancer.
[3] J. Seong,et al. Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[4] C. Kuo,et al. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma. , 2014, International journal of radiation oncology, biology, physics.
[5] Y. Paik,et al. Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma , 2014, Radiation oncology journal.
[6] J. Seong,et al. Radiotherapeutic Options for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis , 2014, Liver Cancer.
[7] J. Seong,et al. Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma , 2013, Yonsei medical journal.
[8] W. Koom,et al. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma , 2013, Journal of radiation research.
[9] W. Choi,et al. Treatment Outcomes of Helical Intensity-Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma , 2013, Gut and liver.
[10] K. Hasegawa,et al. A Worldwide Survey of the Current Daily Practice in Liver Surgery , 2013, Liver Cancer.
[11] P. Chow,et al. Liver Transplantation for Hepatocellular Carcinoma: An Appraisal of Current Controversies , 2012, Liver Cancer.
[12] Chae Jihye,et al. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma. , 2012, Liver cancer.
[13] C. Porta,et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. , 2012, Journal of hepatology.
[14] J. Belghiti,et al. Liver Resection and Transplantation in Hepatocellular Carcinoma , 2012, Liver Cancer.
[15] M. Kudo. Treatment of Advanced Hepatocellular Carcinoma with Emphasis on Hepatic Arterial Infusion Chemotherapy and Molecular Targeted Therapy , 2012, Liver Cancer.
[16] Yoon-Koo Kang,et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial. , 2012, European journal of cancer.
[17] R. Lencioni. Chemoembolization in Patients with Hepatocellular Carcinoma , 2012, Liver Cancer.
[18] J. Seong,et al. Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma , 2011, Oncology.
[19] L. Dawson. Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies? , 2011, Seminars in Radiation Oncology.
[20] S. Ahn,et al. Early α‐fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[21] Hyun-Ki Yoon,et al. Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection , 2010, Annals of Surgical Oncology.
[22] Riccardo Lencioni,et al. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[23] J. Bruix,et al. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.
[24] David D. Smith,et al. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. , 2008, American journal of surgery.
[25] K. Saigenji,et al. Potential Prognostic Benefits of Radiotherapy as an Initial Treatment for Patients with Unresectable Advanced Hepatocellular Carcinoma with Invasion to Intrahepatic Large Vessels , 2008, Oncology.
[26] Chang-Min Kim,et al. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. , 2007, International journal of radiation oncology, biology, physics.
[27] C. Suh,et al. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[28] R. T. Ten Haken,et al. Partial volume tolerance of the liver to radiation. , 2005, Seminars in radiation oncology.
[29] M. Choi,et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. , 2005, International journal of radiation oncology, biology, physics.
[30] J. Sung,et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. , 2004, International journal of radiation oncology, biology, physics.
[31] J. Seong,et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. , 2003, International journal of radiation oncology, biology, physics.
[32] C. Suh,et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[33] W. Guo,et al. Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. , 2000, The British journal of radiology.
[34] R. T. Ten Haken,et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] S. Fan,et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence , 2000, Journal of surgical oncology.
[36] Zeng-chen Ma,et al. Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma , 1998, Digestive Surgery.
[37] J. Okamura,et al. Transcatheter chemo‐embolization effective for treating hepatocellular carcinoma. A histopathologic study , 1984, Cancer.
[38] Yee Lee Cheah,et al. Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. , 2012, Liver cancer.
[39] [Practice guidelines for management of hepatocellular carcinoma 2009]. , 2009, The Korean journal of hepatology.
[40] Z. Tang,et al. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. , 1998, Digestive surgery.
[41] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.